Haben Sie sich noch nicht registriert? Hier kostenlos Ihr Konto eröffnen.
Passwort vergessen? Wir werden Ihnen einen Zurücksetzen Link senden
1 Mai 2024
TRYP THERAPEUTICS AND EXOPHARM LIMITED ANNOUNCE COMPLETION OF PLAN OF ARRANGEMENT
24 April 2024
TRYP THERAPEUTICS PROVIDES UPDATE ON PLAN OF ARRANGEMENT WITH EXOPHARM LIMITED AND ANNOUNCES VOLUNTARY TRADING HALT
12 März 2024
TRYP THERAPEUTICS ANNOUNCES 99.92% VOTES CAST BY SHAREHOLDERS IN FAVOR OF ARRANGEMENT AGREEMENT AT ANNUAL GENERAL AND SPECIAL MEETING OF SECURITYHOLDERS, AND RECEIPT OF FINAL ORDER
8 Februar 2024
TRYP THERAPEUTICS OBTAINS INTERIM ORDER FOR PLAN OF ARRANGEMENT AND PROVIDES DETAILS OF SHAREHOLDER MEETING
26 Januar 2024
TRYP THERAPEUTICS AND EXOPHARM LIMITED SECURE PIVOTAL 2 CENT WAIVER FROM ASX
8 Januar 2024
TRYP THERAPEUTICS ANNOUNCES SIGNIFICANT MILESTONE IN ITS CLINICAL TRIAL PROGRAM FOR TRP-8803 (IV-INFUSED PSILOCIN)